Predictive Oncology Reports Q3 Earnings with EPS Beat and Revenue Miss
Predictive Oncology (AGPU) reported third-quarter financial results characterized by a significant earnings beat alongside a revenue shortfall. The company posted GAAP earnings per share (EPS) of $0.52, surpassing analyst expectations by $0.81. However, the company's revenue for the quarter reached $7.24 million, falling short of consensus estimates by $2.06 million. This mixed performance highlights a divergence between profitability metrics and top-line growth during the period.

Tickers: $POAI
Topics: earnings beat GAAP EPS revenue miss
Read the full article at Seeking Alpha
Part of the story Tencent Music Entertainment Reports Q3 Revenue Miss Despite Meeting Earnings Expectations (7 articles)